一种方法学框架可识别设计个性化干预时应考虑的个人组学标志物
本研究旨在建立方法学框架,识别并优先排序设计个性化戒烟干预时应考虑的个人组学标志物(如社会心理状况、信念等)。研究从研究证据中识别36个标志物,经795名医生和793名患者在11963次配对比较中评估,用Bradley-Terry-Luce模型分析。医生认为戒烟动机、患者偏好及恐惧与信念最相关;患者认为戒烟动机、吸烟行为及烟草依赖最相关。
要点
- 建立方法学框架可识别并优先排序个性化干预应考虑的个人组学标志物。
- 医生认为戒烟动机、患者偏好及恐惧与信念是戒烟干预最相关的个性化要素。
- 患者认为戒烟动机、吸烟行为及烟草依赖是最相关的个性化要素。
核心结论
- 提供了一种方法学框架,用于优先排序开发戒烟干预时应考虑的个人组学标志物。
研究设计与样本
- 研究分两步:首先从个性化干预方案、戒烟预测因素综述及全科医生访谈中识别潜在个人组学标志物;然后由医生和患者吸烟者或戒烟者通过在线配对比较实验选择最相关标志物,数据用Bradley-Terry-Luce模型分析。
- 共795名医生(中位年龄34岁,IQR 30-38;95%为全科医生)和793名患者(中位年龄54岁,IQR 42-64;71.4%为戒烟者)参与评估。
主要发现
- 从研究证据中识别出36个个人组学标志物。
- 共进行11963次配对比较。
- 医生认为最相关的个性化要素为患者戒烟动机(如Prochaska阶段)、患者偏好及患者恐惧与信念(如对体重增加的担忧)。
- 患者认为最相关的要素为戒烟动机、吸烟行为(如在家/在工作场所吸烟)及烟草依赖(如Fagerström测试)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop a methodological framework to identify and prioritize personomic markers (e.g., psychosocial situation, beliefs…) to consider for personalizing interventions and to test in smoking cessation interventions. STUDY DESIGN AND SETTING: (1) We identified potential personomic markers considered in protocols of personalized interventions, in reviews of predictors of smoking cessation, and in interviews with general practitioners. (2) Physicians, and patient smokers or former smokers selected the markers they considered most relevant during online paired comparison experiments. Data were analyzed with Bradley Terry Luce models. RESULTS: Thirty-six personomic markers were identified from research evidence. They were evaluated by 795 physicians (median age: 34, IQR [30-38]; 95% general practitioners) and 793 patients (median age: 54, IQR [42-64], 71.4% former smokers) during 11,963 paired comparisons. Physicians identified patients' motivation for quitting (e.g., Prochaska stages), patients' preferences, and patients' fears and beliefs (e.g., concerns about weight gain) as the most relevant elements to personalize smoking cessation. Patients considered their motivation for quitting, smoking behavior (e.g., smoking at home/at work), and tobacco dependence (e.g., Fagerström Test) as the most relevant elements to consider. CONCLUSION: We provide a methodological framework to prioritize which personomic markers should be considered when developing smoking cessation interventions.
引用
- Malmartel A, Ravaud P, Tran VT, et al. A methodological framework allows the identification of personomic markers to consider when designing personalized interventions. J Clin Epidemiol. 2023. PMID: 37311514. doi:10.1016/j.jclinepi.2023.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。